Me. Newman, SEROTONIN INHIBITION OF ADENYLATE-CYCLASE IN HUMAN PLATELET MEMBRANES- RELATION TO 5-HT-1A RECEPTOR-MEDIATED ACTIVITY, Biochemical pharmacology, 48(9), 1994, pp. 1677-1682
Serotonin inhibited both basal and forskolin-stimulated adenylate cycl
ase activity in human platelet membranes by approx. 30%, with an EC(50
) of 54 nM. Addition of NaCl to the assay medium reduced the degree of
inhibition. 5-carboxamidotryptamine (5-CT) behaved as a full agonist
in this system (EC(50) of 5.4 nM) and BMY 7378 as a partial agonist (i
nducing 19% inhibition); the putative 5-HT-1a receptor agonists meterg
oline, spiroxatrine and MDL 73005 were inactive. The 5-HT-1a receptor
antagonists metitepin and NAN-190 behaved as antagonists with K-b or K
-i values of 11.2 and 1.17 nM, respectively. Spiperone behaved as a pa
rtial antagonist only. Epinephrine and 5-HT produced convergent, non-a
dditive inhibition of both basal and forskolin-stimulated cyclase.